THOR PHOTOMEDICINE EU LIMITED

THOR Photomedicine EU Limited is a global leader in photobiomodulation (PBM) technology, delivering advanced laser and LED light‑therapy solutions to hospitals, clinics and home‑care settings. Since its founding in 1993, THOR has built an unrivalled research and development pedigree, collaborating with leading universities and amassing more than 1 700 randomised controlled trials and over 11 000 scientific publications that underpin its evidence‑based products.

The company’s portfolio spans high‑power Class IV and 3B lasers for rapid analgesia, as well as low‑power LED systems that promote tissue repair, reduce inflammation and accelerate wound healing. All devices carry the full suite of regulatory clearances – FDA, CE, TGA and NATO – and are listed on the US GSA and eCAT procurement platforms, ensuring they meet the strictest safety and performance standards. THOR also offers comprehensive after‑sales support, including service, repairs and purchase enquiries, alongside a rich library of research resources for clinicians and therapists.

With more than 5 000 customers across over 70 countries, THOR’s vision is to make drug‑free pain relief and enhanced healing accessible in every department of every hospital, every doctor’s office and every home. Their commitment to scientific rigour and patient‑centred care makes them a trusted partner for healthcare professionals worldwide.